|
1
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Igney FH and Krammer PH: Death and
anti-death: Tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharom FJ: ABC multidrug transporters:
Structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Declèves X, Amiel A, Delattre JY and
Scherrmann JM: Role of ABC transporters in the chemoresistance of
human gliomas. Curr Cancer Drug Targets. 6:433–445. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu C and Shervington A: Chemoresistance in
gliomas. Mol Cell Biochem. 312:71–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakagawa T, Ido K, Sakuma T, Takeuchi H,
Sato K and Kubota T: Prognostic significance of the
immunohistochemical expression of O6-methylguanine-DNA
methyltransferase, P-glycoprotein, and multidrug resistance
protein-1 in glioblastomas. Neuropathology. 29:379–388. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Declèves X, Fajac A, Lehmann-Che J, Tardy
M, Mercier C, Hurbain I, Laplanche JL, Bernaudin JF and Scherrmann
JM: Molecular and functional MDR1-Pgp and MRPs expression in human
glioblastoma multiforme cell lines. Int J Cancer. 98:173–180. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tivnan A, Zakaria Z, OLeary C, Kögel D,
Pokorny JL, Sarkaria JN and Prehn JHM: Inhibition of multidrug
resistance protein 1 (MRP1) improves chemotherapy drug response in
primary and recurrent glioblastoma multiforme. Front Neurosci.
9:2182015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peigñan L, Garrido W, Segura R, Melo R,
Rojas D, Cárcamo JG, San Martín R and Quezada C: Combined use of
anticancer drugs and an inhibitor of multiple drug
resistance-associated protein-1 increases sensitivity and decreases
survival of glioblastoma multiforme cells in vitro. Neurochem Res.
36:1397–1406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salvador JAR, Moreira VM, Gonçalves BMF,
Leal AS and Jing Y: Ursane-type pentacyclic triterpenoids as useful
platforms to discover anticancer drugs. Nat Prod Rep. 29:1463–1479.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Banno N, Akihisa T, Tokuda H, Yasukawa K,
Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J and
Nishino H: Triterpene acids from the leaves of Perilla
frutescens and their anti-inflammatory and antitumor-promoting
effects. Biosci Biotechnol Biochem. 68:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee MS and Thuong PT: Stimulation of
glucose uptake by triterpenoids from Weigela subsessilis.
Phytother Res. 24:49–53. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alvarado-Castillo C, Estrada O and
Carvajal E: Pomolic acid, triterpenoid isolated from Licania
pittieri, as competitive antagonist of ADP-induced aggregation
of human platelets. Phytomedicine. 19:484–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park JH, Cho YY, Yoon SW and Park B:
Suppression of MMP-9 and FAK expression by pomolic acid via
blocking of NF-κB/ERK/mTOR signaling pathways in growth
factor-stimulated human breast cancer cells. Int J Oncol.
49:1230–1240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernandes J, Castilho RO, da Costa MR,
Wagner-Souza K, Kaplan Coelho MA and Gattass CR: Pentacyclic
triterpenes from Chrysobalanaceae species: Cytotoxicity on
multidrug resistant and sensitive leukemia cell lines. Cancer Lett.
190:165–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fernandes J, Weinlich R, Castilho RO,
Kaplan MA, Amarante-Mendes GP and Gattass CR: Pomolic acid triggers
mitochondria-dependent apoptotic cell death in leukemia cell line.
Cancer Lett. 219:49–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshida M, Fuchigami M, Nagao T, Okabe H,
Matsunaga K, Takata J, Karube Y, Tsuchihashi R, Kinjo J, Mihashi K,
et al: Antiproliferative constituents from Umbelliferae plants VII.
Active triterpenes and rosmarinic acid from Centella
asiatica. Biol Pharm Bull. 28:173–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Youn SH, Lee JS, Lee MS, Cha EY, Thuong
PT, Kim JR and Chang ES: Anticancer properties of pomolic
acid-induced AMP-activated protein kinase activation in MCF7 human
breast cancer cells. Biol Pharm Bull. 35:105–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoo KH, Park JH, Lee DK, Fu YY, Baek NI
and Chung IS: Pomolic acid induces apoptosis in SK-OV-3 human
ovarian adenocarcinoma cells through the mitochondrial-mediated
intrinsic and death receptor-induced extrinsic pathways. Oncol
Lett. 5:386–390. 2013.PubMed/NCBI
|
|
24
|
Fernandes J, Weinlich R, Castilho RO,
Amarante-Mendes GP and Gattass CR: Pomolic acid may overcome
multidrug resistance mediated by overexpression of anti-apoptotic
Bcl-2 proteins. Cancer Lett. 245:315–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandes J, da Fonseca CO, Teixeira A and
Gattass CR: Perillyl alcohol induces apoptosis in human
glioblastoma multiforme cells. Oncol Rep. 13:943–947.
2005.PubMed/NCBI
|
|
26
|
Shanmugam MK, Nguyen AH, Kumar AP, Tan BK
and Sethi G: Targeted inhibition of tumor proliferation, survival,
and metastasis by pentacyclic triterpenoids: Potential role in
prevention and therapy of cancer. Cancer Lett. 320:158–170. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patlolla JM and Rao CV: Triterpenoids for
cancer prevention and treatment: Current status and future
prospects. Curr Pharm Biotechnol. 13:147–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gheorgheosu D, Duicu O, Dehelean C, Şoica
C and Muntean D: Betulinic acid as a potent and complex antitumor
phytochemical: A minireview. Anticancer Agents Med Chem.
14:936–945. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vasconcelos FC, Gattass CR, Rumjanek VM
and Maia RC: Pomolic acid-induced apoptosis in cells from patients
with chronic myeloid leukemia exhibiting different drug resistance
profile. Invest New Drugs. 25:525–533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ravindran J, Gupta N, Agrawal M, Bhaskar
Bala AS and Rao Lakshmana PV: Modulation of ROS/MAPK signaling
pathways by okadaic acid leads to cell death via, mitochondrial
mediated caspase-dependent mechanism. Apoptosis. 16:145–161. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oliva CR, Moellering DR, Gillespie GY and
Griguer CE: Acquisition of chemoresistance in gliomas is associated
with increased mitochondrial coupling and decreased ROS production.
PLoS One. 6(1–10): e246652011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Faria GP, de Oliveira JA, de Oliveira
JG, Romano SO, Neto VM and Maia RC: Differences in the expression
pattern of P-glycoprotein and MRP1 in low-grade and high-grade
gliomas. Cancer Invest. 26:883–889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abe T, Mori T, Wakabayashi Y, Nakagawa M,
Cole SP, Koike K, Kuwano M and Hori S: Expression of multidrug
resistance protein gene in patients with glioma after chemotherapy.
J Neurooncol. 40:11–18. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin F, Zhao L, Guo YJ, Zhao WJ, Zhang H,
Wang HT, Shao T, Zhang SL, Wei YJ, Feng J, et al: Influence of
Etoposide on anti-apoptotic and multidrug resistance-associated
protein genes in CD133 positive U251 glioblastoma stem-like cells.
Brain Res. 1336:103–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Happold C, Roth P, Wick W, Schmidt N,
Florea AM, Silginer M, Reifenberger G and Weller M: Distinct
molecular mechanisms of acquired resistance to temozolomide in
glioblastoma cells. J Neurochem. 122:444–455. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perazzoli G, Prados J, Ortiz R, Caba O,
Cabeza L, Berdasco M, Gónzalez B and Melguizo C: Temozolomide
resistance in glioblastoma cell lines: Implication of MGMT, MMR,
P-Glycoprotein and CD133 expression. PLoS One. 10:e01401312015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Benyahia B, Huguet S, Declèves X and
Mokhtari K: Crinière1 E, Bernaudin JF, Scherrmann JM and Delattre
JY: Multidrug resistance-associated protein MRP1 expression in
human gliomas: chemosensitization to vincristine and etoposide by
indomethacin in human glioma cell lines overexpressing MRP. J
Neurooncol. 66:65–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garrido W, Muñoz M, San Martín R and
Quezada C: FK506 confers chemosensitivity to anticancer drugs in
glioblastoma multiforme cells by decreasing the expression of the
multiple resistance-associated protein-1. Biochem Biophys Res
Commun. 411:62–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lefranc F, Brotchi J and Kiss R: Possible
future issues in the treatment of glioblastomas: Special emphasis
on cell migration and the resistance of migrating glioblastoma
cells to apoptosis. J Clin Oncol. 23:2411–2422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Queiroz RM, Takiya CM, Guimarães LPTP,
Rocha GG, Alviano DS, Blank AF, Alviano CS and Gattass CR:
Apoptosis-inducing effects of Melissa officinalis L.
essential oil in glioblastoma multiforme cells. Cancer Invest.
32:226–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Santos BL, Oliveira MN, Coelho PL, Pitanga
BP, da Silva AB, Adelita T, Silva VD, Mde Costa F, El-Bachá RS,
Tardy M, Chneiweiss H, Junier MP, Moura-Neto V and Costa SL:
Flavonoids suppress human glioblastoma cell growth by inhibiting
cell metabolism, migration, and by regulating extracellular matrix
proteins and metalloproteinases expression. Chem Biol Int.
242:123–138. 2015. View Article : Google Scholar
|
|
43
|
da Fonseca CO, Simão M, Lins IR, Caetano
RO, Futuro D and Quirico-Santos T: Efficacy of monoterpene perillyl
alcohol upon survival rate of patients with recurrent glioblastoma.
J Cancer Res Clin Oncol. 137:287–293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cho HY, Wang W, Jhaveri N, Torres S, Tseng
J, Leong MN, Lee DJ, Goldkorn A, Xu T, Petasis NA, et al: Perillyl
alcohol for the treatment of temozolomide-resistant gliomas. Mol
Cancer Ther. 11:2462–2472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jeremias I, Steiner HH, Benner A, Debatin
KM and Herold-Mende C: Cell death induction by betulinic acid,
ceramide and TRAIL in primary glioblastoma multiforme cells. Acta
Neurochir (Wien). 146:721–729. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li S, Zhu JH, Cao LP, Sun Q, Liu HD, Li
WD, Li JS and Hang CH: Growth inhibitory in vitro effects of
glycyrrhizic acid in U251 glioblastoma cell line. Neurol Sci.
35:1115–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kavitha CV, Jain AK, Agarwal C, Pierce A,
Keating A, Huber KM, Serkova NJ, Wempe MF, Agarwal R and Deep G:
Asiatic acid induces endoplasmic reticulum stress and apoptotic
death in glioblastoma multiforme cells both in vitro and in vivo.
Mol Carcinog. 54:1417–1429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhu Z, Du S, Ding F, Guo S, Ying G and Yan
Z: Ursolic acid attenuates temozolomide resistance in glioblastoma
cells by downregulating O6-methylguanine-DNA
methyltransferase (MGMT) expression. Am J Transl Res. 8:3299–3308,
eCollection. 2016.PubMed/NCBI
|
